Silverfin false false 31/12/2025 01/01/2025 31/12/2025 M P Ansell 05/02/2015 D J Barbour 04/03/2025 H Kelly 06/12/2021 M L Williams 04/03/2025 R T Wyatt-Haines 24/03/2014 S J P Wyatt-Haines 24/03/2014 03 July 2026 The principal activity of the Company during the financial year is that of a digital health company, including the production and licensing of health videos and the design, development and delivery of the CONNECTPlus healthcare application. 08955041 2025-12-31 08955041 bus:Director1 2025-12-31 08955041 bus:Director2 2025-12-31 08955041 bus:Director3 2025-12-31 08955041 bus:Director4 2025-12-31 08955041 bus:Director5 2025-12-31 08955041 bus:Director6 2025-12-31 08955041 2024-12-31 08955041 core:CurrentFinancialInstruments 2025-12-31 08955041 core:CurrentFinancialInstruments 2024-12-31 08955041 core:Non-currentFinancialInstruments 2025-12-31 08955041 core:Non-currentFinancialInstruments 2024-12-31 08955041 core:ShareCapital 2025-12-31 08955041 core:ShareCapital 2024-12-31 08955041 core:SharePremium 2025-12-31 08955041 core:SharePremium 2024-12-31 08955041 core:RetainedEarningsAccumulatedLosses 2025-12-31 08955041 core:RetainedEarningsAccumulatedLosses 2024-12-31 08955041 core:Goodwill 2024-12-31 08955041 core:Goodwill 2025-12-31 08955041 core:ComputerEquipment 2024-12-31 08955041 core:ComputerEquipment 2025-12-31 08955041 bus:OrdinaryShareClass1 2025-12-31 08955041 bus:OrdinaryShareClass2 2025-12-31 08955041 bus:PreferenceShareClass3 2025-12-31 08955041 core:WithinOneYear 2025-12-31 08955041 core:WithinOneYear 2024-12-31 08955041 core:BetweenOneFiveYears 2025-12-31 08955041 core:BetweenOneFiveYears 2024-12-31 08955041 core:MoreThanFiveYears 2025-12-31 08955041 core:MoreThanFiveYears 2024-12-31 08955041 2025-01-01 2025-12-31 08955041 bus:FilletedAccounts 2025-01-01 2025-12-31 08955041 bus:SmallEntities 2025-01-01 2025-12-31 08955041 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 08955041 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 08955041 bus:Director1 2025-01-01 2025-12-31 08955041 bus:Director2 2025-01-01 2025-12-31 08955041 bus:Director3 2025-01-01 2025-12-31 08955041 bus:Director4 2025-01-01 2025-12-31 08955041 bus:Director5 2025-01-01 2025-12-31 08955041 bus:Director6 2025-01-01 2025-12-31 08955041 core:Goodwill core:TopRangeValue 2025-01-01 2025-12-31 08955041 core:Goodwill 2025-01-01 2025-12-31 08955041 core:ComputerEquipment core:TopRangeValue 2025-01-01 2025-12-31 08955041 2024-01-01 2024-12-31 08955041 core:ComputerEquipment 2025-01-01 2025-12-31 08955041 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 08955041 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 08955041 bus:OrdinaryShareClass2 2025-01-01 2025-12-31 08955041 bus:OrdinaryShareClass2 2024-01-01 2024-12-31 08955041 bus:PreferenceShareClass1 2025-01-01 2025-12-31 08955041 bus:PreferenceShareClass1 2024-01-01 2024-12-31 08955041 bus:PreferenceShareClass2 2025-01-01 2025-12-31 08955041 bus:PreferenceShareClass2 2024-01-01 2024-12-31 08955041 bus:PreferenceShareClass3 2025-01-01 2025-12-31 08955041 bus:PreferenceShareClass3 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 08955041 (England and Wales)

HEALTH AND CARE INNOVATIONS LIMITED

Unaudited Financial Statements
For the financial year ended 31 December 2025
Pages for filing with the registrar

HEALTH AND CARE INNOVATIONS LIMITED

Unaudited Financial Statements

For the financial year ended 31 December 2025

Contents

HEALTH AND CARE INNOVATIONS LIMITED

BALANCE SHEET

As at 31 December 2025
HEALTH AND CARE INNOVATIONS LIMITED

BALANCE SHEET (continued)

As at 31 December 2025
Note 2025 2024
£ £
Fixed assets
Intangible assets 3 71,269 82,509
Tangible assets 4 4,499 2,326
75,768 84,835
Current assets
Debtors 5 243,354 151,969
Cash at bank and in hand 64,849 9,402
308,203 161,371
Creditors: amounts falling due within one year 6 ( 365,413) ( 458,421)
Net current liabilities (57,210) (297,050)
Total assets less current liabilities 18,558 (212,215)
Creditors: amounts falling due after more than one year 7 ( 475,000) ( 566,124)
Net liabilities ( 456,442) ( 778,339)
Capital and reserves
Called-up share capital 8 275 200
Share premium account 922,514 64,945
Profit and loss account ( 1,379,231 ) ( 843,484 )
Total shareholders' deficit ( 456,442) ( 778,339)

For the financial year ending 31 December 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Health and Care Innovations Limited (registered number: 08955041) were approved and authorised for issue by the Board of Directors on 03 July 2026. They were signed on its behalf by:

R T Wyatt-Haines
Director
HEALTH AND CARE INNOVATIONS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2025
HEALTH AND CARE INNOVATIONS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Health and Care Innovations Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 5 The Rocklands, Chudleigh, Newton Abbot, TQ13 0EA, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence following post year-end investment, and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Profit and Loss Account in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Turnover

Turnover comprises the fair value of the consideration received or receivable for the transformation of pathways of care using video, apps and other digital resources in the ordinary course of the company's activities, and is shown net of sales/value added tax.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Employee benefits

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Profit and Loss Account in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either other debtors or other creditors in the Balance Sheet.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date. Tax is recognised in the profit and loss account, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Goodwill 10 years straight line
Goodwill

Goodwill arises on business combinations and represents any excess of consideration given over the fair value of the identifiable assets and liabilities acquired. Goodwill is initially recognised as an intangible asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Computer equipment 3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Leases

The Company as lessee
Rentals are under operating leases and are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Loans and borrowings
Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 14 12

3. Intangible assets

Goodwill Total
£ £
Cost
At 01 January 2025 112,400 112,400
At 31 December 2025 112,400 112,400
Accumulated amortisation
At 01 January 2025 29,891 29,891
Charge for the financial year 11,240 11,240
At 31 December 2025 41,131 41,131
Net book value
At 31 December 2025 71,269 71,269
At 31 December 2024 82,509 82,509

4. Tangible assets

Computer equipment Total
£ £
Cost
At 01 January 2025 15,519 15,519
Additions 4,531 4,531
At 31 December 2025 20,050 20,050
Accumulated depreciation
At 01 January 2025 13,193 13,193
Charge for the financial year 2,358 2,358
At 31 December 2025 15,551 15,551
Net book value
At 31 December 2025 4,499 4,499
At 31 December 2024 2,326 2,326

5. Debtors

2025 2024
£ £
Trade debtors 128,810 94,635
Corporation tax 97,429 45,481
Other debtors 17,115 11,853
243,354 151,969

6. Creditors: amounts falling due within one year

2025 2024
£ £
Bank loans 5,273 10,000
Trade creditors 10,719 15,649
Other taxation and social security 46,698 60,147
Other creditors 302,723 372,625
365,413 458,421

7. Creditors: amounts falling due after more than one year

2025 2024
£ £
Bank loans 0 6,124
Other creditors 475,000 560,000
475,000 566,124

8. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
15,047 Ordinary shares of £ 0.01 each (2024: 10,500 shares of £ 0.01 each) 150 105
9,267 A Ordinary shares of £ 0.01 each (2024: nil shares) 93 0
Nil Ordinary A shares (2024: 5,500 shares of £ 0.01 each) 0 55
Nil Ordinary B shares (2024: 4,000 shares of £ 0.01 each) 0 40
243 200
3,157 A Preference shares of £ 0.01 each (2024: nil shares) 32 0
275 200

9. Financial commitments

Commitments

Total future minimum lease payments under non-cancellable operating leases are as follows:

2025 2024
£ £
Within one year 8,580 8,580
Between one and five years 32,175 34,320
After five years 0 6,435
40,755 49,335